Daridorexant
HealthData.Gov
Updated Mar 25, 2026
About this dataset
Quviviq (daridorexant) is a prescription medication by Idorsia Pharmaceuticals Ltd, classified as an orexin receptor antagonist. It's used to treat insomnia in adults and comes as oral tablets in 25mg and 50mg strengths. As a Schedule IV controlled substance, it helps promote sleep by blocking orexin receptors. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Daridorexant
Access the FDA dataset for Daridorexant β ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025